NCT04949191 2024-09-19The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies.Incyte CorporationPhase 2 Terminated10 enrolled 9 charts
NCT00779428 2015-10-12Clinical Trial of Continuing Treatment for Patients Who Have Participated on a Prior Protocol Investigating TanespimycinBristol-Myers SquibbPhase 2 Completed6 enrolled